BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16983080)

  • 1. Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy.
    Sasaki K; Heeschen C; Aicher A; Ziebart T; Honold J; Urbich C; Rossig L; Koehl U; Koyanagi M; Mohamed A; Brandes RP; Martin H; Zeiher AM; Dimmeler S
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14537-41. PubMed ID: 16983080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
    Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic nervous system regulates bone marrow-derived cell egress through endothelial nitric oxide synthase activation: role in postischemic tissue remodeling.
    Récalde A; Richart A; Guérin C; Cochain C; Zouggari Y; Yin KH; Vilar J; Drouet I; Lévy B; Varoquaux O; Silvestre JS
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):643-53. PubMed ID: 22267478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.
    Wohlfart P; Xu H; Endlich A; Habermeier A; Closs EI; Hübschle T; Mang C; Strobel H; Suzuki T; Kleinert H; Förstermann U; Ruetten H; Li H
    J Pharmacol Exp Ther; 2008 May; 325(2):370-9. PubMed ID: 18252813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways.
    de Nigris F; Balestrieri ML; Williams-Ignarro S; D'Armiento FP; Lerman LO; Byrns R; Crimi E; Palagiano A; Fatigati G; Ignarro LJ; Napoli C
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):424-33. PubMed ID: 18049311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.
    Fraccarollo D; Widder JD; Galuppo P; Thum T; Tsikas D; Hoffmann M; Ruetten H; Ertl G; Bauersachs J
    Circulation; 2008 Aug; 118(8):818-27. PubMed ID: 18678774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia.
    Seeger FH; Rasper T; Koyanagi M; Fox H; Zeiher AM; Dimmeler S
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1802-9. PubMed ID: 19696399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model.
    Urano T; Ito Y; Akao M; Sawa T; Miyata K; Tabata M; Morisada T; Hato T; Yano M; Kadomatsu T; Yasunaga K; Shibata R; Murohara T; Akaike T; Tanihara H; Suda T; Oike Y
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):827-34. PubMed ID: 18258819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells.
    Aicher A; Heeschen C; Mildner-Rihm C; Urbich C; Ihling C; Technau-Ihling K; Zeiher AM; Dimmeler S
    Nat Med; 2003 Nov; 9(11):1370-6. PubMed ID: 14556003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow CXCR4 induction by cultivation enhances therapeutic angiogenesis.
    Shiba Y; Takahashi M; Hata T; Murayama H; Morimoto H; Ise H; Nagasawa T; Ikeda U
    Cardiovasc Res; 2009 Jan; 81(1):169-77. PubMed ID: 18791205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E positively modulates endothelial progenitor cell homeostasis: an advanced treatment modality for autologous cell therapy.
    Herrler T; Leicht SF; Huber S; Hermann PC; Schwarz TM; Kopp R; Heeschen C
    J Vasc Res; 2009; 46(4):333-46. PubMed ID: 19142013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury.
    Frantz S; Adamek A; Fraccarollo D; Tillmanns J; Widder JD; Dienesch C; Schäfer A; Podolskaya A; Held M; Ruetten H; Ertl G; Bauersachs J
    Basic Res Cardiol; 2009 Nov; 104(6):773-9. PubMed ID: 19548059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells.
    Urbich C; Heeschen C; Aicher A; Dernbach E; Zeiher AM; Dimmeler S
    Circulation; 2003 Nov; 108(20):2511-6. PubMed ID: 14581410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
    Mehta VB; Zhou Y; Radulescu A; Besner GE
    Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in vascular permeability and vasodilation are critical for proangiogenic effects of stem cell therapy.
    You D; Waeckel L; Ebrahimian TG; Blanc-Brude O; Foubert P; Barateau V; Duriez M; Lericousse-Roussanne S; Vilar J; Dejana E; Tobelem G; Lévy BI; Silvestre JS
    Circulation; 2006 Jul; 114(4):328-38. PubMed ID: 16847153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy.
    Assmus B; Tonn T; Seeger FH; Yoon CH; Leistner D; Klotsche J; Schächinger V; Seifried E; Zeiher AM; Dimmeler S
    J Am Coll Cardiol; 2010 Mar; 55(13):1385-94. PubMed ID: 20338501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursolic acid induces allograft inflammatory factor-1 expression via a nitric oxide-related mechanism and increases neovascularization.
    Lee AW; Chen TL; Shih CM; Huang CY; Tsao NW; Chang NC; Chen YH; Fong TH; Lin FY
    J Agric Food Chem; 2010 Dec; 58(24):12941-9. PubMed ID: 21070071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia.
    Ruifrok WP; de Boer RA; Iwakura A; Silver M; Kusano K; Tio RA; Losordo DW
    Vasc Med; 2009 Feb; 14(1):29-36. PubMed ID: 19144777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats.
    Gao L; Yu DM
    Chin Med J (Engl); 2008 Nov; 121(21):2129-33. PubMed ID: 19080171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.